Amedisys Board Determines Optum Proposal Could Reasonably be Expectedto Result in a Superior Proposal Amedisys Engaging in Discussions with Optum BATON ROUGE, La., June 05, 2023 . | June 5, 2023
/PRNewswire/ Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2023. Three-Month Periods Ended.
All-Stock Transaction Combines Highly Complementary Businesses Unlocking Significant Benefits for Patients, Providers, Payers, and Care Teams Increases Access.
BATON ROUGE, La., May 3, 2023 /PRNewswire/ Amedisys, Inc. today reported its financial results for the three-month period ended March 31, 2023. . | June 17, 2023